DFX Intelligence

This investor

Managing Director

As of 2026-10-01 · this person's identity; each section below carries its own date

Current roles: 1
Investments attributed: 1
Board seats: 0

View relationships Find contacts Investments Board seats

As of 2026-10-01 · this person's identity; each section below carries its own date

The investor's name, its current firm

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

1 deal
12 months
1 investment attributed in the last 12 months; latest Allink Biotherapeutics Series A ($47M) on 16 Dec 2025.
A partner with a recent deal is actively writing cheques now.
Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →

Relationship network

2 connected entities1 observed investment recordinvestment records 2025

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Some relationships on this record are counted rather than named here. They open with the full profile.

This person

Managing Director

1 more firm or role on this record

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Reading the network

Company

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to this person: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to this person

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

1 current, 0 past

this investor Managing Director
? to present
Fact Press release

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Allink Biotherapeutics	Series A · $47.0M · Series A	this investor	confirmed	Dec 16, 2025	Fact source on record

Board seats and vehicles

0 boards, 0 vehicles

None on record.

Timeline

1 dated entry: events, attributed deals, board seats and role changes

Dec 16, 2025
Series A in Allink Biotherapeutics (this investor)
Attributed investment Fact Allink Biotherapeutics Press release